SCHEMBL1377901

SCHEMBL1377901

O=C(NCCC1CCC1)c1ccc(N2CCN(C(=O)c3cc(F)ccc3C(F)(F)F)CC2)nn1

nearest known ligand 0.93

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SCD O00767 14/20 0.93
DCTPP1 Q9H773 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL936814 0.97 SCD (1.00) SCDDCTPP1
SCHEMBL29438734 0.97 SCD (1.00) SCDDCTPP1
SCHEMBL1380588 0.95 SCD (0.93) SCDDCTPP1
SCHEMBL1377534 0.92 SCD (0.90) SCDDCTPP1
SCHEMBL1377027 0.91 SCD (0.93) SCDDCTPP1
SCHEMBL1379099 0.90 SCD (1.00) SCDDCTPP1
SCHEMBL1378674 0.89 SCD (0.93) SCDDCTPP1
SCHEMBL1599828 0.88 SCD (0.84) SCDDCTPP1
SCHEMBL1380172 0.87 SCD (1.00) SCDDCTPP1
SCHEMBL1378078 0.87 SCD (0.83) SCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4808616-B2 2011-11-02 JP claimed
EP-1648874-B1 PIPERAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC (CA) 2011-10-05 EP claimed
EP-1846035-B1 COMBINATION THERAPY XENON PHARMACEUTICALS INC (CA) 2011-09-21 EP claimed
EP-1846035-B1 COMBINATION THERAPY XENON PHARMACEUTICALS INC (CA) 2011-09-21 EP disclosed
US-7919484-B2 Combination therapy XENON PHARMACEUTICALS INC. (CA) 2011-04-05 US disclosed